Match!

Resistance to pyridine-based inhibitor KF116 reveals an unexpected role of integrase in HIV-1 Gag-Pol polyprotein proteolytic processing

Published on Dec 1, 2017in Journal of Biological Chemistry4.106
· DOI :10.1074/jbc.M117.816645
Ashley C. Hoyte4
Estimated H-index: 4
(University of Colorado Denver),
Augusta Jamin4
Estimated H-index: 4
(Harvard University)
+ 5 AuthorsMamuka Kvaratskhelia35
Estimated H-index: 35
(University of Colorado Denver)
Abstract
Abstract The pyridine-based multimerization selective HIV-1 integrase (IN) inhibitors (MINIs) are a distinct subclass of allosteric IN inhibitors. MINIs potently inhibit HIV-1 replication during virion maturation by inducing hyper- or aberrant IN multimerization but are largely ineffective during the early steps of viral replication. Here, we investigated the mechanism for the evolution of a triple IN substitution (T124N/V165I/T174I) that emerges in cell culture with a representative MINI, KF116. We show that HIV-1 NL4-3(IN T124N/V165I/T174I) confers marked (>2000-fold) resistance to KF116. Two IN substitutions (T124N/T174I) directly weaken inhibitor binding at the dimer interface of the catalytic core domain but at the same time markedly impair HIV-1 replication capacity. Unexpectedly, T124N/T174I IN substitutions inhibited proteolytic processing of HIV-1 polyproteins Gag and Gag-Pol, resulting in immature virions. Strikingly, the addition of the third IN substitution (V165I) restored polyprotein processing, virus particle maturation, and significant levels of replication capacity. These results reveal an unanticipated role of IN for polyprotein proteolytic processing during virion morphogenesis. The complex evolutionary pathway for the emergence of resistant viruses, which includes the need for the compensatory V165I IN substitution, highlights a relatively high genetic barrier exerted by MINI KF116. Additionally, we have solved the X-ray structure of the drug-resistant catalytic core domain protein, which provides means for rational development of second-generation MINIs.
  • References (41)
  • Citations (3)
📖 Papers frequently viewed together
45 Citations
12 Citations
42 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References41
Newest
: Retroviral replication proceeds through the integration of a DNA copy of the viral RNA genome into the host cellular genome, a process that is mediated by the viral integrase (IN) protein. IN catalyzes two distinct chemical reactions: 3'-processing, whereby the viral DNA is recessed by a di- or trinucleotide at its 3'-ends, and strand transfer, in which the processed viral DNA ends are inserted into host chromosomal DNA. Although IN has been studied as a recombinant protein since the 1980s, de...
6 CitationsSource
#1Allison Ballandras-Colas (Francis Crick Institute)H-Index: 5
#2D.P. Maskell (Francis Crick Institute)H-Index: 5
Last. Peter Cherepanov (Imperial College London)H-Index: 37
view all 14 authors...
Retroviral integrase (IN) functions within the intasome nucleoprotein complex to catalyze insertion of viral DNA into cellular chromatin. Using cryo–electron microscopy, we now visualize the functional maedi-visna lentivirus intasome at 4.9 angstrom resolution. The intasome comprises a homo-hexadecamer of IN with a tetramer-of-tetramers architecture featuring eight structurally distinct types of IN protomers supporting two catalytically competent subunits. The conserved intasomal core, previousl...
33 CitationsSource
#1D.O. Passos (Salk Institute for Biological Studies)H-Index: 4
#2Min Li (NIH: National Institutes of Health)H-Index: 10
Last. Dmitry Lyumkis (Salk Institute for Biological Studies)H-Index: 19
view all 10 authors...
Like all retroviruses, HIV-1 irreversibly inserts a viral DNA (vDNA) copy of its RNA genome into host target DNA (tDNA). The intasome, a higher-order nucleoprotein complex composed of viral integrase (IN) and the ends of linear vDNA, mediates integration. Productive integration into host chromatin results in the formation of the strand transfer complex (STC) containing catalytically joined vDNA and tDNA. HIV-1 intasomes have been refractory to high-resolution structural studies. We used a solubl...
55 CitationsSource
#1Kushol Gupta (UPenn: University of Pennsylvania)H-Index: 19
#2Vesa Turkki (UPenn: University of Pennsylvania)H-Index: 1
Last. Frederic D. Bushman (UPenn: University of Pennsylvania)H-Index: 101
view all 14 authors...
The allosteric inhibitors of integrase (termed ALLINIs) interfere with HIV replication by binding to the viral-encoded integrase (IN) protein. Surprisingly, ALLINIs interfere not with DNA integration but with viral particle assembly late during HIV replication. To investigate the ALLINI inhibitory mechanism, we crystallized full-length HIV-1 IN bound to the ALLINI GSK1264 and determined the structure of the complex at 4.4 A resolution. The structure shows GSK1264 buried between the IN C-terminal...
15 CitationsSource
#1Jacques J. Kessl (OSU: Ohio State University)H-Index: 21
#2Sebla B. Kutluay (Aaron Diamond AIDS Research Center)H-Index: 12
Last. Mamuka Kvaratskhelia (OSU: Ohio State University)H-Index: 35
view all 11 authors...
While an essential role of HIV-1 integrase (IN) for integration of viral cDNA into human chromosome is established, studies with IN mutants and allosteric IN inhibitors (ALLINIs) have suggested that IN can also influence viral particle maturation. However, it has remained enigmatic as to how IN contributes to virion morphogenesis. Here, we demonstrate that IN directly binds the viral RNA genome in virions. These interactions have specificity, as IN exhibits distinct preference for select viral R...
24 CitationsSource
#1Juan Fontana (NIH: National Institutes of Health)H-Index: 16
#2Kellie A. Jurado (Harvard University)H-Index: 6
Last. Alasdair C. Steven (NIH: National Institutes of Health)H-Index: 85
view all 8 authors...
During virion maturation, HIV-1 capsid protein assembles into a conical core containing the viral ribonucleoprotein (vRNP) complex, thought to be composed mainly of the viral RNA and nucleocapsid protein (NC). After infection, the viral RNA is reverse transcribed into double-stranded DNA, which is then incorporated into host chromosomes by integrase (IN) catalysis. Certain IN mutations (class II) and antiviral drugs (allosteric IN inhibitors [ALLINIs]) adversely affect maturation, resulting in v...
34 CitationsSource
#1Alison Slaughter (OSU: Ohio State University)H-Index: 10
#2Kellie A. Jurado (Harvard University)H-Index: 6
Last. Mamuka Kvaratskhelia (OSU: Ohio State University)H-Index: 35
view all 15 authors...
Background: Allosteric HIV-1 integrase (IN) inhibitors (ALLINIs) are an important new class of anti-HIV-1 agents. ALLINIs bind at the IN catalytic core domain (CCD) dimer interface occupying the principal binding pocket of its cellular cofactor LEDGF/p75. Consequently, ALLINIs inhibit HIV-1 IN interaction with LEDGF/p75 as well as promote aberrant IN multimerization. Selection of viral strains emerging under the inhibitor pressure has revealed mutations at the IN dimer interface near the inhibit...
19 CitationsSource
#1Hind J. Fadel (Mayo Clinic)H-Index: 14
#2James H. Morrison (Mayo Clinic)H-Index: 8
Last. Eric M. Poeschla (Mayo Clinic)H-Index: 38
view all 7 authors...
HIV-1 utilizes the cellular protein LEDGF/p75 as a chromosome docking and integration cofactor. The LEDGF/p75 gene, PSIP1, is a potential therapeutic target because, like CCR5, depletion of LEDGF/p75 is tolerated well by human CD4+ T cells, and knockout mice have normal immune systems. RNA interference (RNAi) has been useful for studying LEDGF/p75, but the potent cofactor activity of small protein residua can be confounding. Here, in human cells with utility for HIV research (293T and Jurkat), w...
50 CitationsSource
#1Nikki van Bel (UvA: University of Amsterdam)H-Index: 5
#2Yme U. van der Velden (UvA: University of Amsterdam)H-Index: 3
Last. Ben Berkhout (UvA: University of Amsterdam)H-Index: 76
view all 7 authors...
The viral integrase (IN) is an essential protein for HIV-1 replication. IN inserts the viral dsDNA into the host chromosome, thereby aided by the cellular co-factor LEDGF/p75. Recently a new class of integrase inhibitors was described: allosteric IN inhibitors (ALLINIs). Although designed to interfere with the IN-LEDGF/p75 interaction to block HIV DNA integration during the early phase of HIV-1 replication, the major impact was surprisingly found on the process of virus maturation during the lat...
15 CitationsSource
#1Kushol Gupta (UPenn: University of Pennsylvania)H-Index: 19
#2Troy Brady (UPenn: University of Pennsylvania)H-Index: 17
Last. Frederic D. Bushman (UPenn: University of Pennsylvania)H-Index: 101
view all 12 authors...
HIV-1 replication in the presence of antiviral agents results in evolution of drug-resistant variants, motivating the search for additional drug classes. Here we report studies of GSK1264, which was identified as a compound that disrupts the interaction between HIV-1 integrase (IN) and the cellular factor lens epithelium-derived growth factor (LEDGF)/p75. GSK1264 displayed potent antiviral activity and was found to bind at the site occupied by LEDGF/p75 on IN by x-ray crystallography. Assays of ...
40 CitationsSource
Cited By3
Newest
Last. Marc RuffH-Index: 23
view all 12 authors...
Using coevolution-network interference based on the comparison of two phylogenetically distantly related isolates, one from the main group M and the other from the minor group O of HIV-1, we identify, in the C-terminal domain (CTD) of integrase, a new functional motif constituted by four non-contiguous amino acids (N222K240N254K273). Mutating the lysines abolishes integration through decreased 39-processing and inefficient nuclear import of reverse transcribed genomes. Solution of the crystal st...
Source
#1Tomofumi Nakamura (Kumamoto University)H-Index: 1
#2Teruya Nakamura (Kumamoto University)H-Index: 12
Last. Hirotomo Nakata (Kumamoto University)H-Index: 14
view all 7 authors...
HIV-1 integrase (IN) contributes to HIV-1 RNA binding, which is required for viral maturation. Non-catalytic site integrase inhibitors (NCINIs) have been developed as allosteric IN inhibitors, which perform anti-HIV-1 activity by disrupting IN multimerization. Here, we show that IN undergoes a novel conformational alteration to escape from NCINIs. We observed that NCINI-resistant HIV-1 variants have accumulated amino acid (AA) mutations in the IN-encoding region. We employed HPLC and thermal sta...
Source
Antiretroviral inhibitors that are used to manage HIV infection/AIDS predominantly target three enzymes required for virus replication: reverse transcriptase, protease, and integrase. Although integrase inhibitors were the last among this group to be approved for treating people living with HIV, they have since risen to the forefront of treatment options. Integrase strand transfer inhibitors (INSTIs) are now recommended components of frontline and drug-switch antiretroviral therapy formulations....
7 CitationsSource
#1Pratibha C. Koneru (CU: University of Colorado Boulder)H-Index: 5
#2Ashwanth C. Francis (Emory University)H-Index: 5
Last. Mamuka Kvaratskhelia (CU: University of Colorado Boulder)H-Index: 35
view all 15 authors...
HIV-1 inserts its genetic code into human genomes, turning healthy cells into virus factories. To do this, the virus uses an enzyme called integrase. Front-line treatments against HIV-1 called “integrase strand-transfer inhibitors” stop this enzyme from working. These inhibitors have helped to revolutionize the treatment of HIV/AIDS by protecting the cells from new infections. But, the emergence of drug resistance remains a serious problem. As the virus evolves, it changes the shape of its integ...
2 CitationsSource
#1M. Galilee (Technion – Israel Institute of Technology)
#2Akram Alian (Technion – Israel Institute of Technology)H-Index: 12
New anti-AIDS treatments must be continually developed in order to overcome resistance mutations including those emerging in the newest therapeutic target, the viral integrase (IN). Multimerization of IN is functionally imperative and provides a forthcoming therapeutic target. Allosteric inhibitors of IN bind to non-catalytic sites and prevent correct multimerization not only restricting viral integration but also the assembly and maturation of viral particles. Here, we report an allosteric inhi...
Source